A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

Project: Research project

Description

A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
StatusActive
Effective start/end date2/27/192/28/20

Funding

  • Children's Hospital of Philadelphia

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Young Adult
Inotuzumab Ozogamicin